Cantech Letter

Founded in 2008 by Nick Waddell, Cantech Letter is an online magazine focusing on Canadian technology. The site has grown into one of the most popular and respected financial sites in Canada, and was described by Canadian Business Magazine as “one of Canada’s premier technology newsletters”. Waddell, who is Senior Editor, is routinely called on by the mainstream media for perspective on Canadian technology, and has been featured on BNN, CTV News Channel, and the CBC program “The Lang and O’Leary Exchange” in addition to mainstream print media such as The Guardian, The International Business Times, The Globe and Mail, Macleans, The Waterloo Record , Canadian Business, Slate, and Business Insider. You can email Nick at nick@cantechletter.com Cantech Letter is focused on those companies listed on the TSX and TSXV Technology, Cleantech and Life Sciences Sectors. Each year we present the Cantech Letter Awards, which honor Canada’s Top Technology Stock and Top Technology Stock Executive.

Visit Blog

Authors

Nick Waddell

Nick is President of Cantech Media and Founding Editor of Cantech Letter. Nick has fifteen years experience with public technology companies in the areas of corporate communications and corporate finance. Nick is also a contributor to publications such as Canadian Business and Business Insider. Prior to this work, Nick was a writer and editor with Monday Publications in Victoria, BC and, in the early 1990’s was a VP with one of the world’s first profitable internet sites, Canadian Stock Market Reporter. Nick majored in English and minored in Economics at The University of Guelph and Simon Fraser University.

Latest Articles

AcuityAds gets new $1.75 target at Haywood

Following the company’s second quarter results, Haywood analyst Pardeep Sangha has raised his price target on AcuityAds (TSXV:AT). On Tuesday, AcuityAds reported its Q2, 2018 results. The company lost $2.24-million on revenue of $11.96-million, a ...

Promis Neurosciences has 79 per cent upside, says Mackie Research

After publishing its second quarter results, Canadian biotech company Promis Neurosciences (TSX:PMN) got a target price reduction from André Uddin of Mackie Research Capital, who now sees a longer timeline for the potential licensing of the company...

Buy CannTrust Holdings for a double, GMP says

Following the company’s second quarter results, GMP Securities analyst Martin Landry is still bullish on CannTrust Holdings (TSX:TRST), if only a little less so. On Tuesday, CannTrust reported its Q2, 2018 results. The company earned $104,905 on r...

Canadian tech stocks are still being overlooked, BMO’s Tyler Hewlett says

Led by the FAANG group of stocks, the tech sector in the United States continues to get plenty of attention, but north of the border the picture is much different, says BMO Canadian Small Cap Equity Fund manager Tyler Hewlett, who argues that tech...

FAANG stocks are due for a fall, Norman Levine says

The FAANG group of companies may be driving market gains these days, even as their valuations look more and more absurd, but for value investors like Norman Levine of the Portfolio Management Corp, history dictates that at some point, the glamour wi...